Market Tracker

02/16 5:15pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.80
Delayed Data
As of Feb 16
 +0.70 / +2.79%
Today’s Change
13.60
Today|||52-Week Range
33.00
+20.28%
Year-to-Date

Today’s Trading

Previous close25.10
Today’s open26.05
Day’s range25.35 - 26.65
Volume645,771
Average volume (3 months)768,539
Market cap$1.2B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-539.47%
Earnings growth (this year)--
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+13.22%
P/E ratioNM
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.12+1.10%
ATNXAthenex Inc-0.11-0.66%
DERMDermira Inc-0.76-2.69%
CLLSCellectis SA+0.29+0.90%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.94
Annual revenue (last year)$588.3M
Annual profit (last year)-$223.4M
Net profit margin-37.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts